Incyte (INCY) Cash from Investing Activities (2010 - 2026)

Incyte (INCY) posted Cash from Investing Activities of -$88.2 million for Q1 2026, down 135.72% on a QoQ basis from -$37.4 million in Q4 2025, and down 8140.38% year-over-year from $1.1 million in Q1 2025.

Incyte (INCY) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Incyte's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$88.2 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 8140.38% year-over-year to -$88.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$191.9 million (down 182.82% YoY) and the FY2025 annual result came in at -$102.6 million, down 165.14% from the prior year.
  • Cash from Investing Activities was -$88.2 million for Q1 2026 at Incyte, down from -$37.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $213.8 million in Q2 2024 and bottomed at -$154.5 million in Q4 2023.
  • A 5-year average of -$18.8 million and a median of -$20.9 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Investing Activities surged 2978.18% — and 2026, when it slumped 8140.38%.
  • Incyte's Cash from Investing Activities stood at -$20.9 million in 2022, then sank by 638.81% to -$154.5 million in 2023, then jumped by 86.11% to -$21.5 million in 2024, then sank by 74.33% to -$37.4 million in 2025, then tumbled by 135.72% to -$88.2 million in 2026.
  • Business Quant data shows INCY's Cash from Investing Activities at -$88.2 million in Q1 2026, -$37.4 million in Q4 2025, and -$47.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Incyte 23.64 Bn 19.62 Bn 1.17 Bn -88.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -88.20 Mn
Mar 31, 2026 -88.20 Mn
Dec 31, 2025 -37.42 Mn
Dec 31, 2025 -37.42 Mn
Sep 30, 2025 -47.42 Mn
Sep 30, 2025 -47.42 Mn
Jun 30, 2025 -18.87 Mn
Jun 30, 2025 -18.87 Mn
Mar 31, 2025 1.10 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 -21.47 Mn
Dec 31, 2024 -21.47 Mn
Sep 30, 2024 38.27 Mn
Sep 30, 2024 38.27 Mn
Jun 30, 2024 213.82 Mn
Jun 30, 2024 213.82 Mn
Mar 31, 2024 -73.11 Mn
Mar 31, 2024 -73.11 Mn
Dec 31, 2023 -154.50 Mn
Dec 31, 2023 -154.50 Mn